M6A plays an important role in the proliferation [82, 106, 120], invasion [80, 83, 106], metastasis [79, 193], drug resistance [197, 198] and prognosis [191] of lung cancer and may become a new molecular therapeutic target. This evidence concerns the gene METTL3 and lung carcinoma.